HLB Therapeutics Co.,Ltd. (KOSDAQ:115450)

HLB Therapeutics Revenue

HLB Therapeutics had revenue of 14.05B KRW in the quarter ending September 30, 2024, a decrease of -26.24%. This brings the company's revenue in the last twelve months to 55.30B, up 25.14% year-over-year. In the year 2023, HLB Therapeutics had annual revenue of 53.75B with 26.76% growth.

• Revenue (ttm): 55.30B
• Revenue Growth: +25.14%
• P/S Ratio: 13.45
• Revenue / Employee: 594.60M
• Employees: 93
• Market Cap: 814.33B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	53.75B	11.35B	26.76%
Dec 31, 2022	42.40B	-1.18B	-2.72%
Dec 31, 2021	43.59B	656.63M	1.53%
Dec 31, 2020	42.93B	-16.04B	-27.20%
Dec 31, 2019	58.97B	15.38B	35.29%